Veeva Systems (VEEV) Stock Price

Veeva Systems Price

NYSE·CLOSED
280.45
​
Market closed

Revenue has compounded at 40.9% per year over the past 16 years to 3.20 B USD. Earnings per share have grown at 41.2% per year over the last 15 years. Veeva Systems's net margin stands at 28.4%, up from 23.1% several years earlier. Analysts set a median price target of 235.00 USD, implying 16.2% below the current price. Of 36 analysts, 26 rate the stock a buy — an overall Buy consensus.

Veeva Systems stock price

Access this data via the Eulerpool API

Veeva Systems business model & stock analysis

The history of Veeva Systems Inc: Veeva Systems is a leading company in the field of cloud software for the life science industry. The company was founded in 2007 and is headquartered in Pleasanton, California. Veeva was created by Peter Gassner and Matt Wallach to improve the management of clinical trials and collaboration in the pharmaceutical industry. Business model of Veeva Systems Inc: The business model of Veeva Systems is focused on improving efficiency and collaboration in the life science industry. The company offers cloud-based software solutions tailored to the needs of life science companies. These solutions include CRM systems, clinical trial management software, data management tools, and analytics tools. Veeva Systems was founded as a CRM company for the life science industry. With its first software, Veeva CRM, the company revolutionized how pharmaceutical companies manage and collaborate with their sales forces. Since then, Veeva Systems has expanded its portfolio and offers a wide range of software solutions, ranging from planning and conducting clinical trials to collecting and analyzing data. Divisions of Veeva Systems Inc: Veeva Systems is divided into three divisions: 1) Commercial Cloud: This division of Veeva Systems provides software solutions for managing customer relationships, sales and marketing activities, and digital marketing for life science companies. 2) Vault: The Vault division of Veeva Systems offers software solutions for managing content, data, and processes involved in clinical trials and other research projects. 3) Data Cloud: This division offers analytics and data management tools that enable life science companies to collect, manage, and analyze their data. Products of Veeva Systems Inc: Veeva CRM: A CRM software solution that allows pharmaceutical companies to control and manage their sales and marketing activities. Veeva Vault: A suite of software solutions that facilitate the management of clinical trials and research projects. Vault provides solutions for electronic data capture, electronic informed consent forms (eICFs), clinical data management, and document management. Veeva Network: A cloud-based platform that enables life science companies to simultaneously collect patient data and advertise for it. Veeva OpenData: A database of contacts and companies from the life science industry that is regularly updated. Veeva Align: A tool for optimizing personnel deployment and ensuring compliance in the sales of life science companies. Veeva Vault QualityOne: A platform for managing quality control processes, including supply chain monitoring, compliance with regulations, and ensuring standards. Conclusion: Veeva Systems has positioned itself as a leading provider of cloud software solutions for the life science industry and offers its portfolio of CRM, clinical trial management, data management, and analytics tools. The company has succeeded in improving collaboration in the pharmaceutical industry by leveraging cloud technologies to increase effectiveness, safety, and compliance.

Frequently asked questions about Veeva Systems

Veeva Systems Inc is a leading cloud-based software company that focuses on providing solutions specifically for the life sciences industry. Their business model revolves around offering industry-specific applications such as customer relationship management (CRM), content management, and data insights for pharmaceutical and biotechnology companies. Veeva Systems Inc enables these organizations to streamline their processes, improve collaboration, and maximize productivity by leveraging their cloud-based platform. With an emphasis on driving innovation and maintaining regulatory compliance, Veeva Systems Inc aims to empower life sciences companies to deliver better products, enhance customer engagement, and drive overall growth within the industry.

Veeva Systems Inc is primarily active in the pharmaceutical and life sciences industries.

The main competitors of Veeva Systems Inc in the market are Salesforce.com, Inc. and Oracle Corporation.

Veeva Systems Inc is a leading provider of cloud-based software solutions for the life sciences industry. Founded in 2007 by Peter Gassner and Matt Wallach, Veeva Systems has a rich history of innovation and growth. The company initially focused on developing customer relationship management (CRM) solutions specifically tailored for pharmaceutical and biotechnology companies. Today, Veeva Systems offers a comprehensive suite of products that empower life sciences organizations to streamline their operations, enhance collaboration, and improve regulatory compliance. With a customer-centric approach and a commitment to delivering industry-specific solutions, Veeva Systems has established itself as a trusted partner in the life sciences sector.

Veeva Systems Inc has achieved several significant milestones since its inception. One of the major accomplishments includes becoming the leading provider of cloud-based software solutions for the life sciences industry. The company has consistently delivered innovative technology, empowering organizations to streamline their operations, improve efficiency, and enhance customer relationships. Veeva Systems Inc has also expanded its global presence by establishing offices in key regions worldwide, building a strong customer base, and forming strategic partnerships with industry leaders. Additionally, the company has received recognition for its commitment to customer success, product innovation, and overall industry impact.

Veeva Systems Inc is primarily present in various countries and regions around the world. As a leading provider of cloud-based software for the life sciences industry, Veeva Systems Inc has an extensive global presence. The company operates in North America, including the United States and Canada, where it is headquartered. Veeva Systems Inc also has a strong presence in Europe, with operations in countries such as the United Kingdom, Germany, France, and Switzerland. Additionally, the company serves clients in the Asia-Pacific region, including countries like Japan, China, and Australia. With its widespread presence, Veeva Systems Inc continues to expand its reach to better serve its customers globally.

Veeva Systems Inc represents a strong commitment to customer success and innovation. The company's corporate philosophy revolves around empowering life sciences and other regulated industries with cloud-based software solutions. Veeva Systems values collaboration, integrity, and excellence in delivering their specialized products and services. With a focus on industry-specific solutions, Veeva Systems aims to streamline processes, improve efficiency, and ensure compliance within highly regulated sectors. Veeva Systems Inc strives to be a trusted partner, offering tailored solutions and continuous support to drive success for their customers in the ever-evolving market.

Analysts currently set an average price target of 242.47 USD for the Veeva Systems stock (median: 235.00 USD), implying -13.5 % versus the latest price. The consensus is based on 36 analyst ratings.

36 analysts currently rate the Veeva Systems stock: 26 recommend buying, 9 holding and 1 selling.

Converted at the current exchange rate, the Veeva Systems share trades at 246.59 EUR (280.45 USD).

The Veeva Systems share (VEEV) is listed on 8 stock exchanges, including: NYSE (VEEV), London (0LO3.L), SIX (Zürich) (VEE.SW), XETRA (VEE.DE), Frankfurt (VEE.F), München (VEE.MU), Düsseldorf (VEE.DU).

Veeva Systems Inc is a US software company specializing in solutions for the life science industry. The company was founded in 2007 by Peter Gassner and is headquartered in Pleasanton, California. Veeva Systems' business model is based on the development and distribution of cloud-based software solutions for the pharmaceutical, biotechnology, and medical device industries. The products are divided into various divisions, including Veeva CRM, Vault, and Network. The Veeva CRM division offers a cloud-based customer relationship management solution tailored to the needs of the life science industry. This solution allows companies to track and manage all interactions with their customers, from doctors and clinics to medical professionals. The solution also provides a range of tools to measure the effectiveness of marketing and sales activities. Veeva Systems' Vault division is a platform for connecting companies operating in the life science industry. Vault solutions cover topics such as document management, inventory management, and quality assurance. The Vault solutions help companies manage and optimize all aspects of their business cycle, from product development to regulatory compliance. Veeva Systems' Network division provides a platform for collaboration and interaction between pharmaceutical companies, medical professionals, and patients. Network solutions include a digital marketing platform, an online community for medical professionals, and a patient engagement solution. Veeva Systems' business model is based on a subscription model, where customers pay for the use of Veeva Systems' software and services. The company earns money in this way and is able to serve its customers and improve its products. Veeva Systems has experienced steady growth in recent years and is now a leading provider of software solutions for the life science industry. The company has over 975 customers in over 165 countries and is a preferred partner for the world's largest pharmaceutical companies. Overall, Veeva Systems' business model offers customers in the life science industry a wide range of products and services to optimize their business processes, accelerate product development, and improve regulatory compliance.

The revenue of Veeva Systems is 3.20 B USD. This figure is based on current financial data and reflects the company's business performance.

The profit of Veeva Systems is 908.91 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Veeva Systems is currently 50.93. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Veeva Systems stock.

The price-to-sales ratio (P/S) of Veeva Systems is currently 14.49. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Veeva Systems stock.

The Eulerpool Quality Score for Veeva Systems is 7/10.

The ISIN of Veeva Systems is US9224751084. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Veeva Systems is A1W5SA. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Veeva Systems is VEEV. The ticker symbol is used to trade Veeva Systems shares on the stock exchange.

Fair ValueTerminal
263.63 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
403,041.25 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website veeva.com
Currency
USD
Initial public offering
Oct 16, 2013
ISIN
US9224751084
Cusip
922475108
Sedol
BFH3N85
Market capitalization
46.10 B USDLarge Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
5.46
P/E ratio
P/Ee 2027
30.37
P/Ee 2028
27.31
P/Ee 2029
24.31
P/Ee 2030
22.07
P/Ee 2031
19.45
P/Se
12.54
EV/EBIT
48.77
P/B Ratio
6.39
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
12.58 %
Gross Margin
75.53 %
EBIT Margin
28.68 %
Net Margin
28.44 %
EPS (Earnings Per Share)
5.51 USD
Net Debt / EBIT
-1.54
Debt/Equity
0.00
Last updated Sep 29, 2026, 9:43 PM

Veeva Systems Ticker

DÜSSELDORF · VEE.DUFRANKFURT · VEE.FLONDON · 0LO3.LLONDON STOCK EXCHANGE · 0LO3.LMUNICH · VEE.MUNEW YORK · VEEVSIX · VEE.SWXETRA · VEE.DE

Veeva Systems FIGI

VEEV:US · BBG001CGB489VEEV:UA · BBG005845P64VEEV:UC · BBG005845P73VEEV:UN · BBG005845P91VEEV:UP · BBG005845PB8VEEV:UB · BBG005845PD6VEEV:UT · BBG005845PF4VEEV:UM · BBG005845PG3VEEV:UX · BBG005845PH2VEEV:UD · BBG005845PP3VEEV:UF · BBG005845PS0VEEV:VY · BBG005845PT9

All fundamentals and in-depth analysis of Veeva Systems

Our stock analysis for Veeva Systems stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Veeva Systems. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.